ELCC 2016: Industry Participation

The European Lung Cancer Conference 2016 (ELCC 2016), is the most important conference in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.

It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.

Fast facts: ELCC 2016

  • Expecting over 1600 international participants
  • Specialists and Key Opinion Leaders (KOLs) from all over the world in one place and as one community
  • 16 educational and 4 key note lectures sessions running over four days
  • An internationally renowned faculty
  • 8 Industry Satellite Symposia
  • Vibrant commercial exhibition
  • Excellent networking opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution of the following organisations in the ELCC Conferences over the years.

Past attendees
Abbott Laboratories Daiichi Sankyo Europe Novartis Oncology
AbbVie Eli Lilly Olympus Medical Systems Europe
Agennix Elsevier Otsuka Pharmaceuticals
Amgen GE Healthcare Pfizer Oncology
Astrazeneca GSK Qiagen
Bayer Schering Pharma Helsinn Healthcare Roche
Bristol-Myers Squibb Karl Storz Rosetta Genomics
Boehringer Ingelheim Merck Serono Sanofi
Clovis Oncology Microsulis Medical Ltd. Varian Medical Systems
Cis Bio International MSD Wisepress Ltd

How can I participate in ELCC 2016?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our conferences.

Contact the ESMO Events Sponsorship Team for more details. We look forward to hearing from you!